Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    18088084 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal;   Mesothelioma;   Ovarian Neoplasms;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Amatuximab (MORab-009)

Study has passed its completion date and status has not been verified in more than two years.